Our pharmacy has considered the threat that COVID-19 poses to public health and we are implementing strategies to minimize exposure to our patients, especially those who are most susceptible to the virus. Click here for updates on how we are serving our patients.
GLP-1 Medications May Increase the Risk of Severe Acid Reflux
A new study finds patients with type 2 diabetes who take GLP-1 receptor agonists are 27% more likely to develop gastroesophageal reflux disease (GERD) compared to those taking other common drugs called SGLT-2 inhibitors.
El servicio de noticias de salud es un servicio para los usuarios de la página web de Tiffany Natural Pharmacy gracias a HealthDay. Tiffany Natural Pharmacy ni sus empleados, agentes, o contratistas, revisan, controlan, o toman responsabilidad por el contenido de los artículos. Por favor busque consejo médico directamente de un farmacéutico o de su médico principal.